AMF is excited to announce a new commitment from Coefficient Giving (CG), a supporter of AMF for 15 years, whose largest-ever grant, made in August 2026, is funding AMF net campaigns in the Democratic Republic of the Congo.
Going forward, CG’s standard practice will be to donate any equity it receives from investments in for-profit AI and biosecurity companies directly to the Against Malaria Foundation (UK).
This gift will not produce cash for some time, so donations today remain as vital as ever.
Why is CG making this gift?
Some of the most important AI safety and biosecurity work happens at for-profit companies. Investing lets CG support them at scale and return some of the value its funding creates to philanthropy. To keep its AI policy work credibly independent, resulting equity will be donated immediately to the Against Malaria Foundation, so that by default, CG does not keep a financial interest in the companies it funds.
Read CG’s full announcement.
Scale
The value of this gift is uncertain and will only become clear over time, but CG expects to make investments totalling in the hundreds of millions of dollars before the end of 2027.
Will the investments donated to AMF be made public?
Yes. By default, CG and AMF will disclose the investments and their scale.
Why AMF?
There is a large funding gap in malaria control. AMF’s model is highly scalable, so it can deploy high levels of funding effectively over the next six years and beyond. CG has high confidence in AMF’s ability to use any funds realised in the coming years through these gifts to achieve significant impact and help drive down malaria over this crucial next decade.
A potentially transformational gift
This is an extraordinary gift to AMF and to the fight against malaria. The potential impact could be transformational. Time will tell. AMF is deeply grateful to Dustin Moskovitz and Cari Tuna, and the wider team at CG, for the support they are showing AMF with this gift and their desire to see malaria gone.
Why now?
CG expects to make several of these investments in the coming years, so it is putting this gift programme in place now.
Will other organisations benefit?
No. CG wishes to support AMF’s malaria control activities through these gifts.
Is AMF investing in AI?
No. AMF is not putting any money into AI companies and does not select or manage the investments, beyond confirming each gift is appropriate for AMF to accept. CG donates the interests to AMF, so AMF will hold an indirect financial interest in these companies, but only as a passive, non-voting beneficiary of any returns. AMF does no AI policy work.
Who decides when to sell?
Not AMF. Decisions about whether and when to sell are made by the manager of the investments; AMF holds only non-voting interests and has no say. AMF’s trustees will decide how AMF uses any proceeds it receives, acting solely in AMF’s charitable interests, and AMF will publish the policy that guides those decisions. We expect to continue working closely with Coefficient Giving and their partners as the portfolio develops and are very grateful for their support.
When will funds reach AMF?
AMF will only receive cash it can use to fund long-lasting insecticidal nets and their distribution, and potentially other malaria control activities, when there is a liquidity event for an investment. Until then, these holdings fund no nets. A liquidity event is a sale of shares to another investor, an acquisition of the company, or an IPO (a stock market listing). Timing is uncertain. It depends on each company’s progress and on when the investments are sold. Cash could be realised in as little as two years, and over a 2 to 7 year period and beyond. The eventual value could be zero. We expect it will not be and hope it will be material.
Why your support still matters now
AMF has funding gaps running into hundreds of millions of dollars over the coming years, and no cash will come from these holdings for some time. We remain as committed as ever to the worldwide community of donors who want to save lives by reducing malaria. Every US$2 still matters: each net protects a mother, her baby and others. AMF’s room for funding over the next six years runs into billions of dollars, so additional donations and grants of every size can be deployed highly effectively.